Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression. [electronic resource]
Producer: 20100608Description: 381-8 p. digitalISSN:- 1473-5741
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma -- drug therapy
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Nasopharyngeal Neoplasms -- drug therapy
- Paclitaxel -- therapeutic use
- Repressor Proteins -- drug effects
- Signal Transduction -- drug effects
- Thrombospondin 1 -- metabolism
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.